Free Trial

Cambridge Cognition (COG) Competitors

Cambridge Cognition logo
GBX 34.50 0.00 (0.00%)
As of 10/16/2025 06:27 AM Eastern

COG vs. KOO, RENX, INHC, FDBK, IQAI, TRLS, DVRG, SENS, EMIS, and CRW

Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.

Cambridge Cognition vs. Its Competitors

Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

In the previous week, Kooth and Kooth both had 1 articles in the media. Kooth's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kooth
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cambridge Cognition
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kooth currently has a consensus target price of GBX 365, indicating a potential upside of 170.37%. Given Kooth's stronger consensus rating and higher probable upside, equities analysts plainly believe Kooth is more favorable than Cambridge Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£66.34M0.73£4.00M£0.081,687.50
Cambridge Cognition£9.05M1.77-£1.58M-£0.04-907.89

Kooth has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

26.4% of Kooth shares are held by institutional investors. Comparatively, 15.8% of Cambridge Cognition shares are held by institutional investors. 30.7% of Kooth shares are held by company insiders. Comparatively, 3.4% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 18.59% 10.12%
Cambridge Cognition -10.07%-68.83%-0.30%

Summary

Kooth beats Cambridge Cognition on 12 of the 14 factors compared between the two stocks.

Get Cambridge Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COG vs. The Competition

MetricCambridge CognitionHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£16.06M£352.73M£6.10B£2.56B
Dividend YieldN/A5.90%5.73%5.32%
P/E Ratio-907.89493.6684.634,380.75
Price / Sales1.77246.69608.5199,586.53
Price / Cash4.3147.1437.8627.90
Price / Book4.755.0512.358.17
Net Income-£1.58M-£15.55M£3.33B£5.89B
7 Day Performance-0.58%-1.93%2.11%-0.61%
1 Month Performance-6.76%2.03%9.40%1.38%
1 Year Performance22.38%15.28%73.46%137.72%

Cambridge Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COG
Cambridge Cognition
N/AGBX 34.50
flat
N/A+24.6%£16.06M£9.05M-907.8980News Coverage
KOO
Kooth
1.4704 of 5 stars
GBX 142
-1.0%
GBX 365
+157.0%
-50.4%£51.14M£66.34M1,775.00478
RENX
Renalytix
N/AGBX 9
+4.7%
N/A+13.9%£36.48M£2.37M-56.25102High Trading Volume
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A+39.3%£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 10.20
-1.4%
N/A-81.6%£4.47M£885.62K-40.0024
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-28.9%£1.77M£538.19K-13.676Gap Up
TRLS
Trellus Health
N/AGBX 0.87
+4.8%
N/A+0.3%£1.40M£359K-17.3031Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.8684 of 5 stars
GBX 2,390
+1.7%
GBX 2,873.67
+20.2%
+21.9%£846.30M£205.66M4,329.71734High Trading Volume

Related Companies and Tools


This page (LON:COG) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners